PubMed COVID-19 Clinical Care

Childhood obesity increased in the first year of Covid-19 with significant disparities across race, ethnicity, and socioeconomic status. Social distancing led to fewer physical activity opportunities but increased screen time and high-calorie food

In Germany, the Apotheken Umschau (Pharmacy review) is a very popular health magazine for lay people, which is available free of charge in pharmacies. In this study, drug advertising in the Apotheken Umschau was critically analyzed. To our knowledge

CONCLUSION: The use of antigen testing in the ambulance service and the emergency department can lead to a quick classification of COVID and non-COVID areas of an emergency department. The measurement accuracy of antigen testing in the ambulance

No abstract

Injuries to the dentofacial region caused by third parties can affect physiological, sensory and esthetic functions with legal repercussions. The personal and social circumstances generated by Covid-19 and the governmental measures taken to control

Drug-Induced Liver Injury (DILI) constitutes hepatic damage attributed to drug exposure. DILI may be categorized as hepatocellular, cholestatic or mixed and might also involve immune responses. When DILI occurs in dose-dependent manner, it is

T cell-based diagnostic tools identify pathogen exposure, but lack differentiation between recent and historic exposures in acute infectious diseases. Here, T cell receptor (TCR) RNA sequencing was performed on HLADR+/CD38+ CD8+ T cell subsets of

CONCLUSION: During the pandemic years, workflow and staffing changes were associated with a decrease in the number of ILS submissions indicating less engagement with a vital component of quality assurance and therefore patient safety. In addition

CONCLUSION: Radiation mean weekly number of courses and fractions between pre-COVID and post-COVID declined with the effect more pronounced in females 70 years. A decrease in fraction number was observed in all cancer types; specifically, breast

CONCLUSION: In the first year of the pandemic, patients who tested positive for COVID-19 between oncologic diagnosis and initial management experienced significant delays in initiation of cancer-directed therapy compared to those who did not test